What bacteriostatic water is
Bacteriostatic water for injection (BWI) is sterile water that contains 0.9% benzyl alcohol by volume. The benzyl alcohol acts as a preservative by inhibiting bacterial growth - it is bacteriostatic (growth-inhibiting) rather than bactericidal (killing). This means bacteria present in very small numbers may survive but will not multiply to dangerous levels in the solution.
The 0.9% concentration is the standard established by the US Pharmacopeia (USP) and equivalent pharmacopeias in other jurisdictions. At this concentration, benzyl alcohol is effective as a preservative while remaining within accepted safety thresholds for the preserved solution.
Why it is used for peptide reconstitution
When a peptide vial is punctured to add diluent or withdraw solution, contaminants can theoretically be introduced. In a plain sterile water solution, any bacteria introduced have nothing to stop their growth - contamination risk compounds with every access. Bacteriostatic water's benzyl alcohol preservative suppresses this growth between uses.
This makes BWI the appropriate choice for multi-dose vials: vials that will be accessed more than once over a period of days or weeks. For research settings where a single vial may be used across multiple experimental sessions, BWI is the standard diluent.
How benzyl alcohol works
Benzyl alcohol disrupts bacterial cell membrane function and inhibits cellular respiration in bacteria. Concentrations effective against bacteria are not acutely toxic to mammalian cells at the dilutions present in BWI, though benzyl alcohol is not without toxicological considerations at higher concentrations - which is why the 0.9% standard exists and why BWI is never used in certain sensitive applications (notably neonatal care, where benzyl alcohol toxicity has been documented at higher cumulative doses).
Bacteriostatic water vs. sterile water for injection
Sterile water for injection (SWFI): No preservative. Must be used immediately after opening. Single-dose only. Appropriate when the entire reconstituted volume will be used at once.
Bacteriostatic water for injection (BWI): Contains 0.9% benzyl alcohol. Multi-dose - usable over weeks when stored refrigerated. The standard for research peptide reconstitution where vials will be accessed multiple times.
Normal saline (0.9% NaCl): Sometimes used as a diluent. Salt content affects tonicity, which matters in some research contexts. Contains no preservative unless specified.
Storage and handling
Unopened BWI vials should be stored at room temperature, away from light, and should not be frozen. Once opened (septum punctured), the vial should be stored refrigerated. Most manufacturers recommend discarding opened vials after 28 days, in line with USP guidelines, even if solution remains.
When adding BWI to a lyophilized peptide, standard reconstitution technique applies: inject slowly down the wall of the vial, swirl gently, and inspect for clarity before use.
References: United States Pharmacopeia (USP) <1>. Injections and Implanted Drug Products. US Pharmacopeial Convention. Gilman AG et al. Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill.
What bacteriostatic water is
Bacteriostatic water for injection (BWI) is sterile water that contains 0.9% benzyl alcohol by volume. The benzyl alcohol acts as a preservative by inhibiting bacterial growth - it is bacteriostatic (growth-inhibiting) rather than bactericidal (killing). This means bacteria present in very small numbers may survive but will not multiply to dangerous levels in the solution.
The 0.9% concentration is the standard established by the US Pharmacopeia (USP) and equivalent pharmacopeias in other jurisdictions. At this concentration, benzyl alcohol is effective as a preservative while remaining within accepted safety thresholds for the preserved solution.
Why it is used for peptide reconstitution
When a peptide vial is punctured to add diluent or withdraw solution, contaminants can theoretically be introduced. In a plain sterile water solution, any bacteria introduced have nothing to stop their growth - contamination risk compounds with every access. Bacteriostatic water's benzyl alcohol preservative suppresses this growth between uses.
This makes BWI the appropriate choice for multi-dose vials: vials that will be accessed more than once over a period of days or weeks. For research settings where a single vial may be used across multiple experimental sessions, BWI is the standard diluent.
How benzyl alcohol works
Benzyl alcohol disrupts bacterial cell membrane function and inhibits cellular respiration in bacteria. Concentrations effective against bacteria are not acutely toxic to mammalian cells at the dilutions present in BWI, though benzyl alcohol is not without toxicological considerations at higher concentrations - which is why the 0.9% standard exists and why BWI is never used in certain sensitive applications (notably neonatal care, where benzyl alcohol toxicity has been documented at higher cumulative doses).
Bacteriostatic water vs. sterile water for injection
Sterile water for injection (SWFI): No preservative. Must be used immediately after opening. Single-dose only. Appropriate when the entire reconstituted volume will be used at once.
Bacteriostatic water for injection (BWI): Contains 0.9% benzyl alcohol. Multi-dose - usable over weeks when stored refrigerated. The standard for research peptide reconstitution where vials will be accessed multiple times.
Normal saline (0.9% NaCl): Sometimes used as a diluent. Salt content affects tonicity, which matters in some research contexts. Contains no preservative unless specified.
Storage and handling
Unopened BWI vials should be stored at room temperature, away from light, and should not be frozen. Once opened (septum punctured), the vial should be stored refrigerated. Most manufacturers recommend discarding opened vials after 28 days, in line with USP guidelines, even if solution remains.
When adding BWI to a lyophilized peptide, standard reconstitution technique applies: inject slowly down the wall of the vial, swirl gently, and inspect for clarity before use.
References: United States Pharmacopeia (USP) <1>. Injections and Implanted Drug Products. US Pharmacopeial Convention. Gilman AG et al. Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill.
